Press Releases

Press Releases

November 20, 2020
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
November 17, 2020
Praxis Precision Medicines Provides Update On PRAX-114 IND Submission For The Treatment Of Major Depressive Disorder
November 9, 2020
Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
October 20, 2020
Praxis Precision Medicines Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
October 15, 2020
Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering
September 17, 2020
Praxis Precision Medicines Expands Leadership Team to Advance its Pipeline for CNS Disorders
June 11, 2020
Praxis Precision Medicines Promotes Business Leader Stuart Chaffee to Chief Financial Officer
May 4, 2020
Praxis Precision Medicines Launches with over $100 Million to Advance Pipeline of High Impact Therapies for Brain Disorders